These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10729365)

  • 1. Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia.
    Löscher W; Richter A
    Eur J Pharmacol; 2000 Mar; 391(3):251-4. PubMed ID: 10729365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brivaracetam and seletracetam, two new SV2A ligands, improve paroxysmal dystonia in the dt sz mutant hamster.
    Hamann M; Sander SE; Richter A
    Eur J Pharmacol; 2008 Dec; 601(1-3):99-102. PubMed ID: 19014930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats.
    Löscher W; Hönack D
    Eur J Pharmacol; 1993 Mar; 232(2-3):147-58. PubMed ID: 8467854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open trial of levetiracetam for segmental and generalized dystonia.
    Hering S; Wenning GK; Seppi K; Poewe W; Mueller J
    Mov Disord; 2007 Aug; 22(11):1649-51. PubMed ID: 17557353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles.
    Genton P; Van Vleymen B
    Epileptic Disord; 2000 Jun; 2(2):99-105. PubMed ID: 10954241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
    Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S
    Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.
    Löscher W; Hönack D; Rundfeldt C
    J Pharmacol Exp Ther; 1998 Feb; 284(2):474-9. PubMed ID: 9454787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata.
    Löscher W; Hönack D; Bloms-Funke P
    Brain Res; 1996 Oct; 735(2):208-16. PubMed ID: 8911659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam.
    Kasteleijn-Nolst Trenité DG; Marescaux C; Stodieck S; Edelbroek PM; Oosting J
    Epilepsy Res; 1996 Nov; 25(3):225-30. PubMed ID: 8956920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis.
    Richter A; Löscher W
    Eur J Pharmacol; 1999 Mar; 369(3):335-8. PubMed ID: 10225372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant hamster model of paroxysmal dystonia.
    Fredow G; Löscher W
    Eur J Pharmacol; 1991 Jan; 192(2):207-19. PubMed ID: 1851702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats.
    Kitano Y; Komiyama C; Makino M; Kasai Y; Takasuna K; Kinoshita M; Yamazaki O; Takazawa A; Yamauchi T; Sakurada S
    Epilepsia; 2005 Oct; 46(10):1561-8. PubMed ID: 16190926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes.
    Noyer M; Gillard M; Matagne A; Hénichart JP; Wülfert E
    Eur J Pharmacol; 1995 Nov; 286(2):137-46. PubMed ID: 8605950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levetiracetam].
    Salas-Puig J; Calleja S
    Neurologia; 2001 Nov; 16(9):427-32. PubMed ID: 11742623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivo.
    Margineanu DG; Wülfert E
    Eur J Pharmacol; 1995 Nov; 286(3):321-5. PubMed ID: 8608796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextrorphan, but not dextromethorphan, exerts weak antidystonic effects in mutant dystonic hamsters.
    Richter A; Löscher W
    Brain Res; 1997 Jan; 745(1-2):336-8. PubMed ID: 9037429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy.
    Gower AJ; Hirsch E; Boehrer A; Noyer M; Marescaux C
    Epilepsy Res; 1995 Nov; 22(3):207-13. PubMed ID: 8991787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel antiepileptic drug, lamotrigine, exerts prodystonic effects in a mutant hamster model of generalized dystonia.
    Richter A; Löschmann PA; Löscher W
    Eur J Pharmacol; 1994 Nov; 264(3):345-51. PubMed ID: 7698175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidystonic efficacy of nitric oxide synthase inhibitors in a rodent model of primary paroxysmal dystonia.
    Richter A; Löschmann PA; Löscher W
    Br J Pharmacol; 2000 Nov; 131(5):921-6. PubMed ID: 11053212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.